The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
Most people who were initially hesitant about getting vaccinated against Covid-19 eventually received the jab, an ...
10d
BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan
BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to ...
Sweeping U.S. policy changes under Health Secretary Robert F. Kennedy Jr. are having a chilling effect on vaccine makers as ...
A change of tone from the US authorities has introduced new uncertainties. Under health secretary and outspoken vaccine ...
The unprecedented changes have led to diminished vaccine usage, and created a drag that will likely dent revenues.
By Blake Brittain Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...
Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, announced that it ...
A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results